December 22, 2011
Medical Device Daily
The Prometheus v. Mayo case was argued at the U.S. Supreme Court earlier in December, and while many of the justices’ questions seemed to reflect positions they were expected to hold, Chief Justice John Roberts asked questions that have prompted at least one patent attorney to speculate that Roberts might find the technology being litigated ineligible for patent protection, which would have a detrimental impact on the future of patents related to diagnostics and personalized medicine. Finnegan partner Denise DeFranco stated if the Court reversed the Federal Circuit, the outcome “could have major implications,” adding, “if they say this claim is invalid, no matter how narrowly they state that, there are a lot of claims like this one” that would be affected
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Award/Ranking
Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings
June 25, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Commentary
U.S. Judge Rules Forum-Selection Clause Bars Zync from Pursuing ITC Trade Secret Case
June 15, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.